Private Placements





Hedge Funds





Mira Life Science Ventures, Inc.




Business: A C-corp. Evergreen Fund structure for early-stage investment, incubation, and development of disruptive innovations in life sciences, including medical devices, therapeutics, diagnostics, and digital health.


Opportunity: The next 20 years are poised to provide the greatest scientific and medical breakthroughs in our lifetimes. With the technological advancements we have seen the last 10 years allowing us to answer questions we never could address before, including advancements in molecular diagnostics, telemedicine, artificial intelligence (AI) for medical data, mobile networks and devices, novel materials, and biosensors, it is expected that we will see a new generation of treatments to address the most pressing unmet medical needs. Mira LSV was established to capitalize on these breakthrough advancements and facilitate their accelerated development leading to improved clinical outcomes, greater patient access and more effective utilization of healthcare system resources.


Why Invest in Mira Life Science Ventures?




Team. highly successful and unique blend of fund management, product development, business leadership, entrepreneurialism and scientific rigour.




Sector. Life & Health Sciences is a key area for investments with high yield returns, however, investing in early-stage, game-changing technologies requires experience and technical expertise, together with an unparalled due diligence process.




Model. The Mira business model is designed to succeed. Flexible, adaptable, capital and tax efficient.




Deal Flow. Management has an unparalleled global network across industry, academia, and traditional VC syndication partners to source opportunities.


Business Model:




Highly flexible C-corp structure with broad investment capabilities & no restrictions. Can invest in companies, in-license patents, incubate technology, innovate, and collect royalties. A compelling alternative to traditional venture funds and private equity. Can take Mira public as well.




Broad & diverse access to opportunities.




Investor/shareholder focused while providing Evergreen returns.


Team: The Mira LSV Team has significant experience in fund and company management and all aspects of product development from discovery to commercialization. Fund management experience: 13 years, 22% IRR, 80x return on original capital.




Dr. Kurt R. Gehlsen, CEO. Over 30 years as an experienced leader, fund manager, inventor, entrepreneur, and developer of marketed products in life sciences.




Dr. Rob Grundy, Head, European Investments. More than 20 years as a drug developer, fund raiser, entrepreneur, business leader, government advisor, and commercial consultant.




Mel Rothberg, Chairman. Over 40 years as an experienced leader, manager, investor, inventor, entrepreneur and developer of products in the life sciences.




Offices: Boca Raton, Florida; Belfast, UK.


Contact: Dr. Kurt Gehlsen,; 520.904.8396.




Index of Private Placements & Hedge Funds




Here is a link to information on our comprehensive investor awareness program.

For more detailed information, please contact one of the following individuals:


William J. Ritger at 561.891.1903 or

David Goodboy at 561.349.7300 or



The Deal Flow section of this website is operated jointly by Palm Beach Hedge Fund Association, Inc., a Florida corporation, and TickerBuzz, LLC, a Florida limited liability company. Neither PBHFA nor TickerBuzz are registered broker-dealers, and they do not give investment advice, endorsement, analysis, or recommendations with respect to any securities. All securities listed here are being offered by, and all information included on this site is the responsibility of the applicable issuer of such securities. Neither PBHFA nor TickerBuzz have taken any steps to verify the adequacy, accuracy, or completeness of any information, and neither PBHFA nor TickerBuzz nor any of their officers, directors, agents, and employees make any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the PBHFA Terms of Use and Privacy Policy. Neither PBHFA nor TickerBuzz make investment recommendations, and no communication, through this website or in any other medium, should be construed as a recommendation for any security offered on or off this investment platform. Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk, and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investments through equity crowdfunding tend to be in earlier stages of development, and their business model, products, and services may not yet be fully developed, operational, or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Additionally, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns. In the most sensible investment strategy for start-up investing, start-ups should only be part of your overall investment portfolio. Further, the start-up portion of your portfolio may include a balanced portfolio of different start-ups. Investments in start-ups are highly illiquid, and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.


This Profile is intended for discussion purposes only; the only definitive source of information regarding this offering is the Company offering documents. This Profile is not a solicitation to buy or sell any security, and must not be relied upon for financial, legal, tax, or any other professional advice. Investor prospects should also carefully research and consider the risks inherent in this investment. The information in this Profile is applicable only as of the date of this Profile and is subject to change without prior notice. Past performance is not indicative of future results. The editor of this Profile is a Managing Member of TickerBuzz. PBHFA has billed this Company $7,500 for various investor introduction services, including this Profile, and PBHFA has agreed to pay TickerBuzz $500 for its editing of this Profile. Neither PBHFA nor TickerBuzz take any compensation relating to the success of any securities offering. November 17, 2020.




Web Hits